GLS-010 Injection

· Guangzhou Gloria Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS-010 Injection, covering 2020-06-11 to 2020-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma [Phase 2]